Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late- clinical stage pipeline products, ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late- clinical stage pipeline products, ... Read More
-
2023 Asia-Pacific Molecular Diagnostics Market in 18 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing ... Read More
-
2023 Global Molecular Diagnostics Market in the US, Europe, Japan - 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... Tests This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies ... Read More
-
2023 Europe Molecular Diagnostics Market in France, Germany, Italy, Spain, UK - 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... Paternity Tests This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of ... Read More
-
2023 Latin America Molecular Diagnostics Market in 22 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or ... Read More
-
Global Soft Tissue Sarcoma Drugs Market Growth (Status and Outlook) 2023-2029
... Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Tissue Sarcoma Drugs sales for 2023 through 2029. With Soft Tissue Sarcoma Drugs sales broken down by region, market ... Read More
-
Patient Positioning Systems Market by Product (Tables (Surgical Table, Imaging Table, Examination Table), Accessories, Application (Surgery, Diagnosis, Cancer Treatment), End User (Hospitals, ASCs, Diagnostic Labs)) - Global Forecast to 2027
... market is projected to reach USD 1.7 billion by 2027 from USD 1.4 billion in 2022, growing at a CAGR of 4.0% during the forecast period. The availability of government support, in funds and grants, ... Read More
-
Rare Disease Treatment Market Size By Drug (Biologics, Non-biologics), By Therapeutic Area (Cancer, Blood-related Disorders, Central Nervous System (CNS), Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Disorders), By Patient (Adult, Pediatric), By Route of Administration (Oral, Injectable), Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032
... Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032 Rare Disease Treatment Market is anticipated to grow considerably through 2032 owing to the increasing prevalence of rare diseases across ... Read More
-
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the eight major markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
HER2 Amplification Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
... Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on HER2 Amplification Tests market for the year ... Read More
-
Hematology Drugs Global Market Briefing 2023
... market was $4.6 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.6% and dermatology drugs ... Read More
-
Cancer Vaccines Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... CAGR of 11.54% during the forecast period. The COVID-19 pandemic had an adverse effect on the global economy and healthcare system. Pharmaceuticals, medical gadgets, and biotechnological items were all affected by the worldwide lockdown. Research ... Read More
-
HPV Testing & PAP Test Market Analysis and Forecast to 2032: By Test Type (HPV Test, PAP Test, Co-test), Application (Cervical Cancer, Vaginal Cancer), Location of Testing (Hospitals & Clinics, Diagnostic Centers, Others), and Region
... The global HPV testing & PAP test market was valued at USD 3.7 billion in 2022 and it is anticipated to grow further till USD 7.2 billion by 2032, at a CAGR of 6.8% during ... Read More
-
CAR T Cell Therapy Market, By Targeted Antigen (CD19, BCMA, HER2, GD2, CD20, CD22, CD30, CD33, HER1, Others (CLDN18, etc.)), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle ... Read More
-
Head and Neck Cancer Diagnostics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... 2022-2027. The COVID-19 pandemic has affected the healthcare systems globally and also had a significant impact on the head and neck cancer diagnosis market. As per the article published in Cancer Connect 2020, doctors from ... Read More
-
Colorectal Cancer Screening Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... of 7.45% during the forecast period. The COVID-19 pandemic had a significant impact on the market. Many countries were in lockdown and suspended trade with other countries, leading to a decline in healthcare services, including ... Read More
-
Middle East and Africa (Mea) Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... to grow with a CAGR of 5.2% over the forecast period. The market will show rapid growth due to the rising number of kidney cancer cases in the region and the increasing R&D expenditure of ... Read More
-
Global Radiation Oncology Market 2023-2027
... on the radiation oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
Europe Colorectal Cancer Screening Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... growing burden of colorectal cancer, and increasing cancer prevention initiatives. According to the WHO (World Health Organization), in Europe, colorectal cancer is considered the second-most common cause of cancer death in men and women. It ... Read More
-
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Re
... immunotherapy drugs market size reached US$ 195.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 327.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028. Immunotherapy drugs ... Read More
-
Point of Care Molecular Diagnostics Market Size by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B, COVID-19}, Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Point of Care Molecular Diagnostics Market is anticipated to register growth through ... Read More
-
Oncolytic Virus Therapies Market by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2023-2028
... size reached US$ 130.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 492.6 Million by 2028, exhibiting a growth rate (CAGR) of 20.90% during 2023-2028. Oncolytic virus therapies are a ... Read More
-
Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact ... Read More
Research Assistance
